Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160 (Q80419720)
Jump to navigation
Jump to search
scientific article published on 29 July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160 |
scientific article published on 29 July 2004 |
Statements
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160 (English)
Kenneth H Mayer
Barney S Graham
Beryl A Koblin
Susan P Buchbinder
Mark J Mulligan
Connie L Celum
Robert B Belshe
M Juliana McElrath
Haynes W Sheppard
Peter B Gilbert
Deborah Lee
29 July 2004